UDG Healthcare is in rude health
The former distribution business United Drug has moved into the far more lucrative and exciting area of specialist healthcare services, which means I’ll be holding on to my stake
Last week, I attended the shareholder meeting of UDG Healthcare in Dublin. This is an impressive business that’s in a transition phase following decades in which it was little more than a distributor and wholesaler of pharma and pharma-related products.
Its share price had been relatively pedestrian in the years when the business was almost entirely distribution-focused – as unexciting and competitive a space as you are likely to find in the healthcare...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Private rental sector remains strong despite Covid-19
Demand continues to outstrip supply in both residential and PRS markets, while developers adapt new build designs to take the pandemic into account
How the programme for government will shape housing
Several strategic changes offer an opportunity for positive reform of planning and development
Comment: US must defuse Covid-19’s ticking time bomb of debt
The United States cannot defeat the pandemic like a military foe but it can learn from looking back at its post-war economic recovery
Comment: The recovery will be more U than V-shaped
Vaccine or no vaccine, the economic consequences of the Covid-19 pandemic are likely to linger well into 2021
